Loading video...

Video Failed to Load

There was a problem loading this video. This could be due to a temporary network issue or the video might be unavailable.

In 2025, Precision Neuroscience received its first FDA clearance, enabling expanded clinical programs with U.S. medical centers. More than 70 patients have been implanted, providing system-level validation across materials, devices, hardware, software, and ML.

Protocol Labs

126,379 subscribers

852,264 views • 5 months ago •via X (Twitter)

Health & Wellness Education Science & Technology

Anya Rossi• Live Now

Private livecam show

0 Comments

No comments available

Comments from the original post will appear here

Related Videos

A video on Douyin (Chinese TikTok) providing a brief run-down of American Communist Party and its First National Convention has received more than 100,000 likes and 160,000 shares. Many in the comments have also expressed solidarity towards fellow Comrades across the Pacific.

A video on Douyin (Chinese TikTok) providing a brief run-down of American Communist Party and its First National Convention has received more than 100,000 likes and 160,000 shares. Many in the comments have also expressed solidarity towards fellow Comrades across the Pacific.

The Great Red Translation Movement

21,344 views • 1 year ago

Infant formula maker ByHeart has expanded its voluntary recall, removing all of its baby formula from shelves. At least 15 babies have been hospitalized across 12 states with infant botulism after consuming ByHeart formula. ByHeart sells an estimated 1% of baby formula in the U.S. and the FDA commissioner says there is no risk of a formula shortage.

Infant formula maker ByHeart has expanded its voluntary recall, removing all of its baby formula from shelves. At least 15 babies have been hospitalized across 12 states with infant botulism after consuming ByHeart formula. ByHeart sells an estimated 1% of baby formula in the U.S. and the FDA commissioner says there is no risk of a formula shortage.

CBS Mornings

10,528 views • 8 months ago

🚨 NEW: More than 1,500 Palestinian patients have died waiting for medical evacuation as more than 16,500 remain trapped in Gaza, the Health Ministry says. Gaza’s Health Ministry said Israel is preventing more than 16,500 patients in need of treatment abroad from leaving the Strip, despite the ceasefire in place since October. Acting Undersecretary Maher Shamiya said more than 1,500 patients who had received medical referrals died before they could be evacuated. Only 1,204 patients have been allowed to leave through the Rafah and Karem Abu Salem crossings since limited medical evacuations resumed on February 1, 2026, after the crossings had been closed for roughly 20 months. Shamiya said Israel was systematically obstructing access to life-saving treatment through prolonged security procedures and severe restrictions at the crossings. He added that many of the patients could be treated inside Gaza if Israel stopped blocking the reconstruction of the territory’s devastated healthcare system and allowed the entry of essential medicines, fuel, and medical supplies. He warned that “every day of delay increases the number of victims and threatens the lives of more patients.” The Health Ministry has previously said 6 to 10 patients die each day from treatable diseases or injuries because they cannot access the care they need. 🎥 Palestinian Health Ministry in Gaza

🚨 NEW: More than 1,500 Palestinian patients have died waiting for medical evacuation as more than 16,500 remain trapped in Gaza, the Health Ministry says. Gaza’s Health Ministry said Israel is preventing more than 16,500 patients in need of treatment abroad from leaving the Strip, despite the ceasefire in place since October. Acting Undersecretary Maher Shamiya said more than 1,500 patients who had received medical referrals died before they could be evacuated. Only 1,204 patients have been allowed to leave through the Rafah and Karem Abu Salem crossings since limited medical evacuations resumed on February 1, 2026, after the crossings had been closed for roughly 20 months. Shamiya said Israel was systematically obstructing access to life-saving treatment through prolonged security procedures and severe restrictions at the crossings. He added that many of the patients could be treated inside Gaza if Israel stopped blocking the reconstruction of the territory’s devastated healthcare system and allowed the entry of essential medicines, fuel, and medical supplies. He warned that “every day of delay increases the number of victims and threatens the lives of more patients.” The Health Ministry has previously said 6 to 10 patients die each day from treatable diseases or injuries because they cannot access the care they need. 🎥 Palestinian Health Ministry in Gaza

Drop Site

45,349 views • 1 month ago

Muhammad Dhaban died in Gaza today after an eight-month battle with Stevens-Johnson syndrome, a rare and life-threatening condition that requires intensive specialist care. That care is unavailable because Israel’s military campaign has systematically devastated Gaza’s health system. Hospitals have been bombed, besieged, or forced out of service. Despite the ceasefire, medical supply chains have been choked, essential drugs blocked, and specialist doctors prevented from entering. With fewer than 50 patients per day allowed to exit via Rafah and more than 20,000 patients awaiting evacuation, critically ill people are trapped in a system that has been deliberately shattered to accelerate the killing of Palestinians.

Muhammad Dhaban died in Gaza today after an eight-month battle with Stevens-Johnson syndrome, a rare and life-threatening condition that requires intensive specialist care. That care is unavailable because Israel’s military campaign has systematically devastated Gaza’s health system. Hospitals have been bombed, besieged, or forced out of service. Despite the ceasefire, medical supply chains have been choked, essential drugs blocked, and specialist doctors prevented from entering. With fewer than 50 patients per day allowed to exit via Rafah and more than 20,000 patients awaiting evacuation, critically ill people are trapped in a system that has been deliberately shattered to accelerate the killing of Palestinians.

Drop Site

43,974 views • 5 months ago

In 2025, PDW supported a series of live exercises across the U.S. and Europe to validate organic precision targeting across land, sea, and air. A C100 equipped with a Leonardo DRS STAG5 successfully marked targets for precision strikes by F-35 and RAF Typhoon aircraft, APKWS rockets, and 120mm precision mortars. These demonstrations showed that small units with a man-packable drone system can identify and engage with high-value targets without relying on manned aircraft. Forces can now find and strike targets at a safer standoff distance with a drone platform that fits in a rucksack. This year our work will continue to expand organic cross-domain dominance, pushing precision, reach, and control further down to the unit level. Read more about the campaign here: Thank you to our reseller partner Edgar Brothers for your support on this milestone campaign.

In 2025, PDW supported a series of live exercises across the U.S. and Europe to validate organic precision targeting across land, sea, and air. A C100 equipped with a Leonardo DRS STAG5 successfully marked targets for precision strikes by F-35 and RAF Typhoon aircraft, APKWS rockets, and 120mm precision mortars. These demonstrations showed that small units with a man-packable drone system can identify and engage with high-value targets without relying on manned aircraft. Forces can now find and strike targets at a safer standoff distance with a drone platform that fits in a rucksack. This year our work will continue to expand organic cross-domain dominance, pushing precision, reach, and control further down to the unit level. Read more about the campaign here: Thank you to our reseller partner Edgar Brothers for your support on this milestone campaign.

PDW

24,124 views • 6 months ago

Former FDA Medical Officer Dr. Josef Witt-Doerring, one of the gatekeepers of the world’s medicine, reveals the first time he realized that prescriptions were hurting people more than helping them. “One thing that I thought was mind-blowing was that we did not study the drugs any longer than about a year, and for me, that was the moment.” He reflects on the guilt he felt after seeing patients harmed while pushing certain prescriptions after saying they were “safe and effective, approved by the FDA,” without providing nuance as to what that actually means and how it only pertained to roughly one year of clinical research. Dr. Josef Witt-Doerring lifts the veil on the reality of the FDA approval process and explains how and why holistic healing can be far more effective for many people in E317 of The Lila Rose Show. Watch.

Former FDA Medical Officer Dr. Josef Witt-Doerring, one of the gatekeepers of the world’s medicine, reveals the first time he realized that prescriptions were hurting people more than helping them. “One thing that I thought was mind-blowing was that we did not study the drugs any longer than about a year, and for me, that was the moment.” He reflects on the guilt he felt after seeing patients harmed while pushing certain prescriptions after saying they were “safe and effective, approved by the FDA,” without providing nuance as to what that actually means and how it only pertained to roughly one year of clinical research. Dr. Josef Witt-Doerring lifts the veil on the reality of the FDA approval process and explains how and why holistic healing can be far more effective for many people in E317 of The Lila Rose Show. Watch.

Lila Rose

17,307 views • 2 months ago

🎉 The best way to start the week is to find out that our MedSAM is finally published today in Nature Communications! **Segment anything in medical images** Paper: arXiv: Data & Code: MedSAM is the first promotable foundation model for medical image segmentation. **Highlights**: ⭐ Before its formal publication, we have received 220 citations and 1400+ GitHub stars 🙏🙏❤️‍🔥❤️‍🔥❤️‍🔥 📊 We curated a large-scale medical image dataset with 1,570,263 image-mask pairs, covering 10 imaging modalities and over 30 cancer types. 🚀 Built on top of SAM (AI at Meta ) with transfer learning, we have significantly enhanced its segmentation performance of medical images. 📈 Comprehensive evaluations of 86 internal validation tasks and 60 external validation tasks demonstrate its better accuracy and robustness than modality-wise specialist models. **What is Next? --- Clinical Translation!!** 🍕Our next goal is to make the model deployable on laptops (CPUs) or other edge devices without reliance on GPUs. We have distilled a lightweight model, LiteMedSAM, offering a speed boost of 10x while maintaining accuracy. Plus, we have integrated it into the 3D Slicer plugin, providing an efficient tool for medical image segmentation. 🌐 To further promote developments in this field, we organize a competition on #CVPR2026: Segment Anything in Medical Images on Laptop! An out-of-the-box baseline has been released to reduce the entry barriers. Welcome to join us to push the boundary further: 🙏 Massive thanks to MetaAI AI at Meta for their open-source project SAM and many reviewers/users for their invaluable feedback. A huge shoutout to my postdoc Jun Ma (JunMa) for his leadership on this project!! UHN AI Hub Vector Institute Peter Munk Cardiac Centre AI Department of Laboratory Medicine & Pathobiology U of T Department of Computer Science University of Toronto University Health Network Brad Wouters 🇨🇦 Barry Rubin MD, PhD, FRCSC Shaf Keshavjee

🎉 The best way to start the week is to find out that our MedSAM is finally published today in Nature Communications! Segment anything in medical images Paper: arXiv: Data & Code: MedSAM is the first promotable foundation model for medical image segmentation. Highlights: ⭐ Before its formal publication, we have received 220 citations and 1400+ GitHub stars 🙏🙏❤️‍🔥❤️‍🔥❤️‍🔥 📊 We curated a large-scale medical image dataset with 1,570,263 image-mask pairs, covering 10 imaging modalities and over 30 cancer types. 🚀 Built on top of SAM (AI at Meta ) with transfer learning, we have significantly enhanced its segmentation performance of medical images. 📈 Comprehensive evaluations of 86 internal validation tasks and 60 external validation tasks demonstrate its better accuracy and robustness than modality-wise specialist models. What is Next? --- Clinical Translation!! 🍕Our next goal is to make the model deployable on laptops (CPUs) or other edge devices without reliance on GPUs. We have distilled a lightweight model, LiteMedSAM, offering a speed boost of 10x while maintaining accuracy. Plus, we have integrated it into the 3D Slicer plugin, providing an efficient tool for medical image segmentation. 🌐 To further promote developments in this field, we organize a competition on #CVPR2026: Segment Anything in Medical Images on Laptop! An out-of-the-box baseline has been released to reduce the entry barriers. Welcome to join us to push the boundary further: 🙏 Massive thanks to MetaAI AI at Meta for their open-source project SAM and many reviewers/users for their invaluable feedback. A huge shoutout to my postdoc Jun Ma (JunMa) for his leadership on this project!! UHN AI Hub Vector Institute Peter Munk Cardiac Centre AI Department of Laboratory Medicine & Pathobiology U of T Department of Computer Science University of Toronto University Health Network Brad Wouters 🇨🇦 Barry Rubin MD, PhD, FRCSC Shaf Keshavjee

Bo Wang

140,208 views • 2 years ago

We are proud to announce that we will be among the first in the world to deploy blood-based biomarkers (blood tests) and confirmatory tests for Alzheimer’s disease and related dementias to patients across primary and specialty care settings—early detection tools that have never before been offered to patients in the clinical setting—as part of the Davos Alzheimer's Collaborative (DAC) Healthcare System Preparedness Accurate Diagnosis project. The effort will be co-led by Fanny Elahi, MD, PhD, Director of Fluid Biomarkers at the Maurice Deane Center for Wellness and Cognitive Health at Mount Sinai, and Georges Naasan, MD, Co-Medical Director of the Deane Center. Read more: Fanny Elahi, MD, PhD Friedman Brain Institute Davos Alzheimer’s Collaborative #BrainHealth #Alzheimers

We are proud to announce that we will be among the first in the world to deploy blood-based biomarkers (blood tests) and confirmatory tests for Alzheimer’s disease and related dementias to patients across primary and specialty care settings—early detection tools that have never before been offered to patients in the clinical setting—as part of the Davos Alzheimer's Collaborative (DAC) Healthcare System Preparedness Accurate Diagnosis project. The effort will be co-led by Fanny Elahi, MD, PhD, Director of Fluid Biomarkers at the Maurice Deane Center for Wellness and Cognitive Health at Mount Sinai, and Georges Naasan, MD, Co-Medical Director of the Deane Center. Read more: Fanny Elahi, MD, PhD Friedman Brain Institute Davos Alzheimer’s Collaborative #BrainHealth #Alzheimers

Icahn School of Medicine at Mount Sinai

18,140 views • 1 year ago

Prince Harry and Meghan Markle visited Palestinian medical evacuees in Jordan on February 25, 2026, as thousands of critically ill children remain trapped in Gaza’s shattered health system. According to the World Health Organization, approximately 4,000 children are currently on urgent medical evacuation waitlists. They are part of more than 18,500 patients overall who need specialized care for war-related trauma, cancer, kidney failure, and other chronic conditions. Since the ceasefire, WHO has facilitated the evacuation of just over 740 patients, including 432 children, as of Monday. Aid agencies warn that at current rates, it could take more than four years to clear the backlog. The scale of injury is staggering. At least 44,500 children have been reported injured since October 2023, including more than 11,000 with life-changing injuries requiring long-term rehabilitation. The UK announced a publicly funded evacuation mission in July 2025 and Prime Minister Keir Starmer said severely ill children from Gaza would receive treatment in NHS hospitals. The first group of 51 children arrived in September 2025 and the government has indicated a maximum of 300 may be admitted. But evacuations remain slow. A UN spokesperson said the holdup is largely bureaucratic, citing limited checkpoint/crossing access and the need for more countries to accept patients. “Egypt and other countries in the region, I know Jordan and others have taken people in, but we need more Member States to take in more people. WHO continues to call for rebuilding Gaza’s health system, reopening medical referrals to the West Bank, including East Jerusalem, expanding acceptance of patients abroad, and ensuring children can return home after treatment. Video includes a question from Gabriel Elizondo.

Prince Harry and Meghan Markle visited Palestinian medical evacuees in Jordan on February 25, 2026, as thousands of critically ill children remain trapped in Gaza’s shattered health system. According to the World Health Organization, approximately 4,000 children are currently on urgent medical evacuation waitlists. They are part of more than 18,500 patients overall who need specialized care for war-related trauma, cancer, kidney failure, and other chronic conditions. Since the ceasefire, WHO has facilitated the evacuation of just over 740 patients, including 432 children, as of Monday. Aid agencies warn that at current rates, it could take more than four years to clear the backlog. The scale of injury is staggering. At least 44,500 children have been reported injured since October 2023, including more than 11,000 with life-changing injuries requiring long-term rehabilitation. The UK announced a publicly funded evacuation mission in July 2025 and Prime Minister Keir Starmer said severely ill children from Gaza would receive treatment in NHS hospitals. The first group of 51 children arrived in September 2025 and the government has indicated a maximum of 300 may be admitted. But evacuations remain slow. A UN spokesperson said the holdup is largely bureaucratic, citing limited checkpoint/crossing access and the need for more countries to accept patients. “Egypt and other countries in the region, I know Jordan and others have taken people in, but we need more Member States to take in more people. WHO continues to call for rebuilding Gaza’s health system, reopening medical referrals to the West Bank, including East Jerusalem, expanding acceptance of patients abroad, and ensuring children can return home after treatment. Video includes a question from Gabriel Elizondo.

Drop Site

20,847 views • 5 months ago

Canada has met its goal of welcoming at least 40,000 Afghans to Canada before the end of 2023. This remains one of the largest Afghan resettlement programs around the world. Read more: We will continue to process existing applications we’ve received and also #WelcomeAfghans through regular immigration programs, including economic, family reunification and refugee resettlement programs: This milestone was made possible through collaboration with key partners, including countries in the region, UNHCR, the UN Refugee Agency, IOM - UN Migration 🇺🇳, and non-governmental organizations. Successful resettlement only happens when communities come together and more than 180 communities across Canada have helped Afghans start their new lives. We appreciate service provider organizations across the country, whose tireless efforts continue to make a meaningful difference.

Canada has met its goal of welcoming at least 40,000 Afghans to Canada before the end of 2023. This remains one of the largest Afghan resettlement programs around the world. Read more: We will continue to process existing applications we’ve received and also #WelcomeAfghans through regular immigration programs, including economic, family reunification and refugee resettlement programs: This milestone was made possible through collaboration with key partners, including countries in the region, UNHCR, the UN Refugee Agency, IOM - UN Migration 🇺🇳, and non-governmental organizations. Successful resettlement only happens when communities come together and more than 180 communities across Canada have helped Afghans start their new lives. We appreciate service provider organizations across the country, whose tireless efforts continue to make a meaningful difference.

IRCC

151,280 views • 2 years ago

🔹 AI drug discovery, validated. Recursion recently announced the first clinical validation of its AI-enabled drug discovery platform – positive Phase 1b/2 data for the ongoing TUPELO study evaluating its AI-identified drug, REC-4881, in Familial Adenomatous Polyposis (FAP). This progressive rare disease affects more than 50,000 people in the U.S. and EU and has no FDA-approved treatments. It results in hundreds to thousands of polyps developing in the colon, and requires a lifetime of invasive surveillance and surgery. Recursion used AI not only to deliver the first potential treatment for this disease but also to quantify – for the first time at scale – the true natural progression of polyp burden in the trial-relevant population. It demonstrates the incredible breakthroughs that can come from merging proprietary data and AI – and the tangible impact on patient lives. 👉 See the full study results here:

🔹 AI drug discovery, validated. Recursion recently announced the first clinical validation of its AI-enabled drug discovery platform – positive Phase 1b/2 data for the ongoing TUPELO study evaluating its AI-identified drug, REC-4881, in Familial Adenomatous Polyposis (FAP). This progressive rare disease affects more than 50,000 people in the U.S. and EU and has no FDA-approved treatments. It results in hundreds to thousands of polyps developing in the colon, and requires a lifetime of invasive surveillance and surgery. Recursion used AI not only to deliver the first potential treatment for this disease but also to quantify – for the first time at scale – the true natural progression of polyp burden in the trial-relevant population. It demonstrates the incredible breakthroughs that can come from merging proprietary data and AI – and the tangible impact on patient lives. 👉 See the full study results here:

Recursion

255,879 views • 7 months ago

The Board of REACT19 regrets to inform our community of the sudden cancellation of this week’s meeting of the Advisory Committee on Immunization Practices (ACIP) at the CDC. The meeting was cancelled following a federal court ruling that blocked recent vaccine policy changes and invalidated the current ACIP advisory panel while legal challenges move forward. For many in our community, this meeting represented a long-awaited opportunity. After more than five years of waiting, patients and families had prepared impact statements in hopes that the urgent need for clinical recognition, research, and care for those suffering from serious post-vaccination conditions would finally be discussed. For those living with these conditions, this cancellation is deeply painful. It means more waiting, more uncertainty, and more time without the clinical guidance needed to help physicians recognize, diagnose, and treat patients who have been suffering for years. Our hearts are with every member of this community who had hoped their voice would finally be heard this week. However, even in this difficult moment, important progress continues. On March 18, REACT19 will still be part of a historic step forward at the CDC. A proposal for a new ICD-10 diagnostic code related to post-COVID-19 vaccination conditions will be presented, opening a public comment period and moving the medical system closer to formally recognizing these patients. Diagnostic codes are more than administrative tools. They are a critical foundation for clinical recognition, medical education, research, insurance coverage, and ultimately the development of treatments. Establishing an ICD-10 code would represent an important step toward building the clinical infrastructure needed to care for patients who have too often been left without answers. While the cancellation of the ACIP meeting is a heartbreaking setback for our community, the work to achieve medical recognition and appropriate care continues. If the U.S. Department of Health and Human Services prevails in its appeal, the ACIP process may resume. In the meantime, REACT19 remains committed to ensuring that the voices of patients are heard and that progress toward recognition, research, and care does not stop. To every patient and family who has shared their story and stood with us through years of uncertainty: we see you, we hear you, and we will continue advocating for the care and recognition you deserve. — Board of Directors REACT19

The Board of REACT19 regrets to inform our community of the sudden cancellation of this week’s meeting of the Advisory Committee on Immunization Practices (ACIP) at the CDC. The meeting was cancelled following a federal court ruling that blocked recent vaccine policy changes and invalidated the current ACIP advisory panel while legal challenges move forward. For many in our community, this meeting represented a long-awaited opportunity. After more than five years of waiting, patients and families had prepared impact statements in hopes that the urgent need for clinical recognition, research, and care for those suffering from serious post-vaccination conditions would finally be discussed. For those living with these conditions, this cancellation is deeply painful. It means more waiting, more uncertainty, and more time without the clinical guidance needed to help physicians recognize, diagnose, and treat patients who have been suffering for years. Our hearts are with every member of this community who had hoped their voice would finally be heard this week. However, even in this difficult moment, important progress continues. On March 18, REACT19 will still be part of a historic step forward at the CDC. A proposal for a new ICD-10 diagnostic code related to post-COVID-19 vaccination conditions will be presented, opening a public comment period and moving the medical system closer to formally recognizing these patients. Diagnostic codes are more than administrative tools. They are a critical foundation for clinical recognition, medical education, research, insurance coverage, and ultimately the development of treatments. Establishing an ICD-10 code would represent an important step toward building the clinical infrastructure needed to care for patients who have too often been left without answers. While the cancellation of the ACIP meeting is a heartbreaking setback for our community, the work to achieve medical recognition and appropriate care continues. If the U.S. Department of Health and Human Services prevails in its appeal, the ACIP process may resume. In the meantime, REACT19 remains committed to ensuring that the voices of patients are heard and that progress toward recognition, research, and care does not stop. To every patient and family who has shared their story and stood with us through years of uncertainty: we see you, we hear you, and we will continue advocating for the care and recognition you deserve. — Board of Directors REACT19

React19 - Official

33,312 views • 4 months ago

ABC News investigated and found more than 3,000 data centers are already operating nationwide At least 1,000 more planned Residents near data centers are seeing much as 50%+ increases on their electric bills “ABC7 has also been covering public meetings over proposed data centers and there are questions about water use and the environment. The i-team in ABC News studied this private company's data center map and found that there are at least 4,302 data center projects across the U.S. Large and small. Of those, 3,038 are currently operational with another 1,203 either under construction or plan for construction. 61 have acquired land. In Illinois, there are 164 operating data centers with another 81 planned for construction. The largest state project plan is in Yorkville. It would be 2 gigawatts and according to the ABC7 data team would use the same energy that would power approximately 1.7 million homes more than every home in the city of Chicago.”

ABC News investigated and found more than 3,000 data centers are already operating nationwide At least 1,000 more planned Residents near data centers are seeing much as 50%+ increases on their electric bills “ABC7 has also been covering public meetings over proposed data centers and there are questions about water use and the environment. The i-team in ABC News studied this private company's data center map and found that there are at least 4,302 data center projects across the U.S. Large and small. Of those, 3,038 are currently operational with another 1,203 either under construction or plan for construction. 61 have acquired land. In Illinois, there are 164 operating data centers with another 81 planned for construction. The largest state project plan is in Yorkville. It would be 2 gigawatts and according to the ABC7 data team would use the same energy that would power approximately 1.7 million homes more than every home in the city of Chicago.”

Wall Street Apes

152,195 views • 5 months ago

📢 PM Mark Carney is in Calgary & he just said this about the Industrial Carbon Tax in Alberta "At its core, it's tightening the TIER system which is the industrial carbon price system here in Alberta. To a level of at least $130 with a pass price from there What does that mean? It means more than a six times increase in the industrial price of carbon, from its effective level which is much lower, than the headline level, the effective level, to the level that's committed to in the agreement... ...It creates the conditions for this big investment in the Pathways Project, the largest in the world, which will have huge reductions in emissions, the equivalent of taking more than 90% of the cars and trucks off the road here in Alberta in the first phase of that project... ...We are going to get to our greenhouse gas objectives, our climate objectives, only through massive investment."

📢 PM Mark Carney is in Calgary & he just said this about the Industrial Carbon Tax in Alberta "At its core, it's tightening the TIER system which is the industrial carbon price system here in Alberta. To a level of at least $130 with a pass price from there What does that mean? It means more than a six times increase in the industrial price of carbon, from its effective level which is much lower, than the headline level, the effective level, to the level that's committed to in the agreement... ...It creates the conditions for this big investment in the Pathways Project, the largest in the world, which will have huge reductions in emissions, the equivalent of taking more than 90% of the cars and trucks off the road here in Alberta in the first phase of that project... ...We are going to get to our greenhouse gas objectives, our climate objectives, only through massive investment."

Kris Sims

23,122 views • 8 months ago

First Lady Aseefa B Zardari visited Spencer Eye Hospital, Lyari, which has been transformed by Mayor Karachi Murtaza Wahab with the support of the Government of Sindh through a successful Public-Private Partnership (PPP) model. Originally established in 1940, the hospital has been beautifully restored while preserving its historic heritage. Today, it serves nearly 4,000 patients daily through its OPD, with all services provided completely free of cost. Since April 2026, more than 700 laser and other specialized procedures have been successfully performed, ensuring quality eye care for thousands. She appreciated the dedication, professionalism, and tireless efforts of the doctors, nurses, and the entire medical staff for their outstanding service to the people.

First Lady Aseefa B Zardari visited Spencer Eye Hospital, Lyari, which has been transformed by Mayor Karachi Murtaza Wahab with the support of the Government of Sindh through a successful Public-Private Partnership (PPP) model. Originally established in 1940, the hospital has been beautifully restored while preserving its historic heritage. Today, it serves nearly 4,000 patients daily through its OPD, with all services provided completely free of cost. Since April 2026, more than 700 laser and other specialized procedures have been successfully performed, ensuring quality eye care for thousands. She appreciated the dedication, professionalism, and tireless efforts of the doctors, nurses, and the entire medical staff for their outstanding service to the people.

PPP Digital Media

11,751 views • 8 days ago

Kinan’s story – like so many others – has touched us at World Health Organization (WHO) deeply. After sustaining severe brain injuries from shrapnel in #Gaza, four-year-old Kinan was left paralysed on one side of his body. With no hope of accessing the care he needed within #Gaza’s battered health system, Kinan will finally receive treatment thanks to support from the World Health Organization (WHO) Medical Evacuation Programme, its local partners, and the government of #Slovenia. Kinan was among seven patients evacuated yesterday to Slovenia for medical care, along with three patients transferred to Türkiye and nine to Jordan. During two years of conflict in Gaza, 8,025 patients have been evacuated to around 30 countries, including over 5,000 children. Yet more than 16,500 people – among them nearly 4,000 children – still await evacuation to receive care that is unavailable in Gaza. We continue to call for more countries to show solidarity with patients in urgent need of specialised care outside Gaza and for the opening of all evacuation corridors, especially to the West Bank, including East Jerusalem.

Kinan’s story – like so many others – has touched us at World Health Organization (WHO) deeply. After sustaining severe brain injuries from shrapnel in #Gaza, four-year-old Kinan was left paralysed on one side of his body. With no hope of accessing the care he needed within #Gaza’s battered health system, Kinan will finally receive treatment thanks to support from the World Health Organization (WHO) Medical Evacuation Programme, its local partners, and the government of #Slovenia. Kinan was among seven patients evacuated yesterday to Slovenia for medical care, along with three patients transferred to Türkiye and nine to Jordan. During two years of conflict in Gaza, 8,025 patients have been evacuated to around 30 countries, including over 5,000 children. Yet more than 16,500 people – among them nearly 4,000 children – still await evacuation to receive care that is unavailable in Gaza. We continue to call for more countries to show solidarity with patients in urgent need of specialised care outside Gaza and for the opening of all evacuation corridors, especially to the West Bank, including East Jerusalem.

Tedros Adhanom Ghebreyesus

32,270 views • 8 months ago

Director of EHS Theodora Scarato is sounding the alarm over Data Centers polluting forever chemicals “Data centers are driving up PFAS, forever chemical pollution. Thousands of drinking water wells in North Carolina have already been contaminated with PFAS linked to semiconductor manufacturing, as have streams in our county recently” “PFAS also is used in data center cooling and fire suppression systems” It’s actually worse than what’s being reported here - More than 7,000 drinking water wells contaminated has been found in recent analyses tied to Data Center supply chains - Other results put private well impacts at over 11,000 across 10 counties This is not speculative. North Carolina DEQ has consent orders, expanded sampling requirements, replacement water provisions and ongoing monitoring tied to the plant. The contamination has been confirmed to be affecting soil, groundwater, the Cape Fear River and thousands of private wells

Director of EHS Theodora Scarato is sounding the alarm over Data Centers polluting forever chemicals “Data centers are driving up PFAS, forever chemical pollution. Thousands of drinking water wells in North Carolina have already been contaminated with PFAS linked to semiconductor manufacturing, as have streams in our county recently” “PFAS also is used in data center cooling and fire suppression systems” It’s actually worse than what’s being reported here - More than 7,000 drinking water wells contaminated has been found in recent analyses tied to Data Center supply chains - Other results put private well impacts at over 11,000 across 10 counties This is not speculative. North Carolina DEQ has consent orders, expanded sampling requirements, replacement water provisions and ongoing monitoring tied to the plant. The contamination has been confirmed to be affecting soil, groundwater, the Cape Fear River and thousands of private wells

Wall Street Apes

31,829 views • 3 days ago

There’s been a lot of buzz surrounding multimodal LLMs in medicine. At the Hiesinger Lab we’ve been building Almanac Chat for over 6 months alongside our collaborators and we’re excited to showcase the first preview! • Almanac Chat is the first truly multimodal medical LLM trained across specialties and modalities (i.e. images, text, video and audio) to serve as a generalist clinical copilot. • The entire stack (e.g. server, client, ML pipeline) is developed and hosted locally to guarantee privacy and flexibility at inference time. • We're looking forward to evaluating our model alongside domain experts at Stanford Medicine in Q2 2024. • We have a a lot more exciting things on the way - see if you can spot a few teasers in the video! 👥: We’re looking to scale our team, model, and hardware. If you're interested in a partnership or working alongside myself and our recent hire Joseph Cho please get in touch!

There’s been a lot of buzz surrounding multimodal LLMs in medicine. At the Hiesinger Lab we’ve been building Almanac Chat for over 6 months alongside our collaborators and we’re excited to showcase the first preview! • Almanac Chat is the first truly multimodal medical LLM trained across specialties and modalities (i.e. images, text, video and audio) to serve as a generalist clinical copilot. • The entire stack (e.g. server, client, ML pipeline) is developed and hosted locally to guarantee privacy and flexibility at inference time. • We're looking forward to evaluating our model alongside domain experts at Stanford Medicine in Q2 2024. • We have a a lot more exciting things on the way - see if you can spot a few teasers in the video! 👥: We’re looking to scale our team, model, and hardware. If you're interested in a partnership or working alongside myself and our recent hire Joseph Cho please get in touch!

Cyril Zakka, MD

85,913 views • 2 years ago

Humacyte is proud to announce that the FDA has granted full approval for Symvess™, a first-in-class, universally implantable, bioengineered human vessel for extremity vascular trauma replacement and repair. This approval is a significant milestone in regenerative medicine, offering a new treatment option for patients with severe arterial injuries. Congratulations to our incredible team and partners who made this possible! Learn more at See the Prescribing Information, including Boxed Warning: INDICATION SYMVESS is an acellular tissue engineered vessel indicated for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid imminent limb loss, and autologous vein graft is not feasible. IMPORTANT SAFETY INFORMATION BOXED WARNING: GRAFT FAILURE -Loss of SYMVESS integrity due to mid-graft rupture or anastomotic failure can result in life threatening hemorrhage. CONTRAINDICATIONS DO NOT use SYMVESS in patients who have a medical condition that would preclude long-term antiplatelet therapy (such as aspirin or clopidogrel) after resolution of acute injuries. WARNINGS & PRECAUTIONS -Graft Rupture: Vascular graft rupture has occurred in patients treated with SYMVESS. Advise patients that arterial bleeding can be life-threatening and to seek emergent medical evaluation for any signs or symptoms of graft rupture such as bleeding, pain and swelling in the extremity, or signs of extremity ischemia. Follow appropriate procedures for handling and administering SYMVESS. -Anastomotic Failure: Anastomotic failure has occurred in patients treated with SYMVESS. In clinical studies of SYMVESS, anastomotic failure occurred within the first 36 days post-implantation. Monitor patients for signs of anastomotic failure such as pain and swelling at the surgical site, decreasing hemoglobin or other signs and symptoms of bleeding. Advise patients to seek urgent medical evaluation if they have any signs or symptoms that may be indicative of anastomotic failure such as bleeding, swelling or worsening pain at the surgical site or changes in color of overlying skin. Follow appropriate procedures for handling and administering SYMVESS. -Thrombosis: Thrombosis has occurred in patients treated with SYMVESS. In clinical trials of SYMVESS, patients received antiplatelet therapy following implantation of SYMVESS to reduce the risk of thrombosis. The risk of thrombosis may increase in patients who discontinue antiplatelet therapy. Anti-platelet therapy is recommended following treatment with SYMVESS. -Transmission of Infectious Diseases: SYMVESS is manufactured using cells and reagents that may transmit infectious diseases or infectious agents. The cells used in the manufacture of SYMVESS are derived from a donor who met the donor eligibility requirements for transmissible infectious diseases. Animal-derived reagents are tested for animal viruses, bacteria, fungi, and mycoplasma before use, but this does not eliminate the risk of transmitting these or other transmissible infectious diseases and disease agents. No transmissible agent infections have been reported during clinical testing. ADVERSE REACTIONS The most common adverse reactions (≥3%) were thrombosis, fever, pain, anastomotic stenosis, rupture or anastomotic failure, and infection. USE IN SPECIFIC POPULATIONS Pediatric Use: The safety and effectiveness of SYMVESS in pediatric patients (0 to 17 years old) have not been established. Geriatric Use: Two patients out of the 54 Extremity Group implanted with SYMVESS as a conduit in Study 1 were aged ≥65 years. The number of patients aged ≥65 years was not sufficient to determine whether they responded differently than younger patients to SYMVESS. #Humacyte #FDAApproval #RegenerativeMedicine #Innovation #Biotech #Firstinclass $HUMA

Humacyte is proud to announce that the FDA has granted full approval for Symvess™, a first-in-class, universally implantable, bioengineered human vessel for extremity vascular trauma replacement and repair. This approval is a significant milestone in regenerative medicine, offering a new treatment option for patients with severe arterial injuries. Congratulations to our incredible team and partners who made this possible! Learn more at See the Prescribing Information, including Boxed Warning: INDICATION SYMVESS is an acellular tissue engineered vessel indicated for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid imminent limb loss, and autologous vein graft is not feasible. IMPORTANT SAFETY INFORMATION BOXED WARNING: GRAFT FAILURE -Loss of SYMVESS integrity due to mid-graft rupture or anastomotic failure can result in life threatening hemorrhage. CONTRAINDICATIONS DO NOT use SYMVESS in patients who have a medical condition that would preclude long-term antiplatelet therapy (such as aspirin or clopidogrel) after resolution of acute injuries. WARNINGS & PRECAUTIONS -Graft Rupture: Vascular graft rupture has occurred in patients treated with SYMVESS. Advise patients that arterial bleeding can be life-threatening and to seek emergent medical evaluation for any signs or symptoms of graft rupture such as bleeding, pain and swelling in the extremity, or signs of extremity ischemia. Follow appropriate procedures for handling and administering SYMVESS. -Anastomotic Failure: Anastomotic failure has occurred in patients treated with SYMVESS. In clinical studies of SYMVESS, anastomotic failure occurred within the first 36 days post-implantation. Monitor patients for signs of anastomotic failure such as pain and swelling at the surgical site, decreasing hemoglobin or other signs and symptoms of bleeding. Advise patients to seek urgent medical evaluation if they have any signs or symptoms that may be indicative of anastomotic failure such as bleeding, swelling or worsening pain at the surgical site or changes in color of overlying skin. Follow appropriate procedures for handling and administering SYMVESS. -Thrombosis: Thrombosis has occurred in patients treated with SYMVESS. In clinical trials of SYMVESS, patients received antiplatelet therapy following implantation of SYMVESS to reduce the risk of thrombosis. The risk of thrombosis may increase in patients who discontinue antiplatelet therapy. Anti-platelet therapy is recommended following treatment with SYMVESS. -Transmission of Infectious Diseases: SYMVESS is manufactured using cells and reagents that may transmit infectious diseases or infectious agents. The cells used in the manufacture of SYMVESS are derived from a donor who met the donor eligibility requirements for transmissible infectious diseases. Animal-derived reagents are tested for animal viruses, bacteria, fungi, and mycoplasma before use, but this does not eliminate the risk of transmitting these or other transmissible infectious diseases and disease agents. No transmissible agent infections have been reported during clinical testing. ADVERSE REACTIONS The most common adverse reactions (≥3%) were thrombosis, fever, pain, anastomotic stenosis, rupture or anastomotic failure, and infection. USE IN SPECIFIC POPULATIONS Pediatric Use: The safety and effectiveness of SYMVESS in pediatric patients (0 to 17 years old) have not been established. Geriatric Use: Two patients out of the 54 Extremity Group implanted with SYMVESS as a conduit in Study 1 were aged ≥65 years. The number of patients aged ≥65 years was not sufficient to determine whether they responded differently than younger patients to SYMVESS. #Humacyte #FDAApproval #RegenerativeMedicine #Innovation #Biotech #Firstinclass $HUMA

Humacyte

27,584 views • 1 year ago